Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 2 of 10
Revolution Medicines, Inc.
Shares:177.1K
Value:$6.3M
Anteris Technologies Global Corp.
Shares:1.7M
Value:$6.1M
G1000R101
Shares:578.4K
Value:$6.0M
Sage Therapeutics, Inc.
Shares:742.5K
Value:$5.9M
89bio, Inc.
Shares:804.2K
Value:$5.8M
NOVARTIS AG
Shares:50.0K
Value:$5.6M
19249HAB9
Shares:
Value:$5.5M
G6717R120
Shares:516.5K
Value:$5.4M
G4444H101
Shares:469.7K
Value:$5.3M
Amylyx Pharmaceuticals, Inc.
Shares:1.5M
Value:$5.2M
Scholar Rock Holding Corp
Shares:157.1K
Value:$5.1M
Xenon Pharmaceuticals Inc.
Shares:127.5K
Value:$4.3M
Xencor Inc
Shares:398.2K
Value:$4.2M
Mineralys Therapeutics, Inc.
Shares:263.4K
Value:$4.2M
Septerna, Inc.
Shares:720.8K
Value:$4.2M
10806XAD4
Shares:
Value:$4.0M
Apogee Therapeutics, Inc.
Shares:104.9K
Value:$3.9M
Savara Inc
Shares:1.4M
Value:$3.8M
Monopar Therapeutics
Shares:100.8K
Value:$3.7M
008064107
Shares:1.5M
Value:$3.7M